ArticleVariation in guideline adherence in intrauterine insemination care
Introduction
Infertility is common. As one in six couples fails to conceive within 1 year of regular unprotected sexual intercourse, approximately 72.4 million couples around the world are currently infertile (Boivin et al., 2007, Taylor, 2003). Roughly half of these couples seek medical care for their fertility problems (Boivin et al., 2007, Nachtigall, 2006). The clinical investigation and treatment of infertility has considerable physical and psychosocial implications for couples (Cousineau and Domar, 2007, Greil, 1997, Hughes, 2003, Verhaak et al., 2005). In addition, fertility treatment often carries a risk of multiple pregnancy which is associated with substantially higher rates of maternal and perinatal morbidity and mortality compared with singletons (Dickey et al., 2005, Fauser et al., 2005). The assessment and treatment of infertility is also expensive and the increased rates of adverse pregnancy outcomes add further to the resources used in health care (Goverde et al., 2000, Lukassen et al., 2004).
It is widely recognized that the quality of health care is often inadequate (Grol and Grimshaw, 2003, McGlynn et al., 2003). As infertility is a major health issue worldwide and its management is associated with health risks and high costs, there is great concern about the impact of substandard infertility care on health and health-care resources (Balen and Rutherford, 2007, Rawal et al., 2008). This prompted several professional societies in the fields of obstetrics and gynaecology, and reproductive medicine as well as governmental agencies to develop clinical practice guidelines for infertility care. These guidelines are tools to help physicians and patients to make better decisions about clinically effective, safe and cost-effective care and reduce inappropriate practice variation in infertility care. Essentially, these guidelines describe ‘the best thing to do’ and aim to improve the outcome of infertility care.
One of the most commonly used fertility treatments is homologous intrauterine insemination (IUI) (Nyboe Andersen et al., 2009). The overall success rate of IUI remains controversial. On average, reported clinical pregnancy rates are only 5–13% per IUI cycle (Bensdorp et al., 2007, Goverde et al., 2000, Guzick et al., 1999, Nyboe Andersen et al., 2009, Steures et al., 2004, Steures et al., 2007, The ESHRE Capri Workshop Group, 2009, Tummon et al., 1997, Verhulst et al., 2006). Poor guideline adherence and a high degree of inappropriate practice variation in IUI care may be responsible for these low pregnancy rates. However, up until now, there has been limited published evidence about guideline adherence in IUI care and the link between guideline adherence and outcome of IUI care. Therefore, the objective of this study was to assess the extent to which practice performance in IUI care is consistent with guideline recommendations and to evaluate the association between guideline adherence and outcome of IUI care.
Section snippets
Study design and population
This retrospective cohort study at 10 Dutch hospitals was conducted using medical record and questionnaire data. The group of participating hospitals was made up of one large academic hospital providing tertiary care and nine medium-sized public hospitals providing secondary care. Five clinics were also teaching hospitals. Patients eligible to participate in the study were defined as infertile couples who underwent IUI treatment at these 10 hospitals during an inclusion period of 28 months, from
Study population
Figure 1 presents the recruitment of eligible infertile couples for participation in the study. A total of 765 infertile couples was willing to participate. The study excluded 184 couples because they had undergone ovulation induction therapy for ovulatory disorders or IUI treatment with donated spermatozoa. Another 23 couples were excluded because there was no access to their medical records. As a result, 558 infertile couples who started a total of 2334 IUI cycles were eligible for study.
Discussion
Although guideline adherence appears adequate for some process and structure aspects of IUI care, on the whole, guideline adherence in IUI care is far from optimal. Also striking is the large variability in guideline adherence between different hospitals. Associations between ⩾90% guideline adherence and ongoing pregnancy after IUI were mainly non-significant.
Acknowledgements
The authors thank the panel of 13 experts who contributed to the development of the indicators. They also thank Sabine van den Akker and Annelies Pellegrino for assisting with data collection and Jan van Doremalen and Reinier Akkermans for assisting with the statistical analyses. The contribution of the 10 Dutch hospitals for participating and making this study possible is gratefully acknowledged: Bernhoven Hospital–Oss, Bernhoven Hospital–Veghel, Canisius Wilhelmina Hospital–Nijmegen,
References (43)
- et al.
Psychological impact of infertility
Best Pract. Res. Clin. Obstet. Gynaecol.
(2007) - et al.
Risk factors for high-order multiple pregnancy and multiple birth after controlled ovarian hyperstimulation: results of 4062 intrauterine insemination cycles
Fertil. Steril.
(2005) - et al.
Multiple birth resulting from ovarian stimulation for subfertility treatment
Lancet
(2005) - et al.
Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis
Lancet
(2000) Infertility and psychological distress: a critical review of the literature
Soc. Sci. Med.
(1997)- et al.
Bias and causal associations in observational research
Lancet
(2002) - et al.
From best evidence to best practice: effective implementation of change in patients’ care
Lancet
(2003) - et al.
How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record
Am. J. Med.
(2000) - et al.
Cost analysis of singleton versus twin pregnancies after in vitro fertilization
Fertil. Steril.
(2004) International disparities in access to infertility services
Fertil. Steril.
(2006)
Intrauterine insemination in The Netherlands
Reprod. Biomed. Online
Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis
Fertil. Steril.
Management of infertility
Br. Med. J.
Intra-uterine insemination for male subfertility
Cochrane Database Syst. Rev.
International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care
Hum. Reprod.
Research methods used in developing and applying quality indicators in primary care
Br. Med. J.
Prescribing indicators for UK general practice. Delphi consultation study
Br. Med. J.
Improvements in quality of clinical care in English general practice 1998–2003: longitudinal observational study
Br. Med. J.
Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability
Int. J. Qual. Health Care
Cited by (14)
Which key performance indicators are most effective in evaluating and managing an in vitro fertilization laboratory?
2020, Fertility and SterilityCost-effectiveness of ovarian stimulation with gonadotrophin and clomiphene citrate in an intrauterine insemination programme for subfertile couples
2018, Reproductive BioMedicine OnlineCitation Excerpt :The cost-effectiveness between IUI with clomiphene citrate or HMG was not analysed in the study by Haagen et al. (2013), as this was not the objective of their study. The fact that we added a model to calculate the ICER based on expecting couples to take part in multiple IUI cycles besides the ICER based on couples taking part in one cycle only, is in line with ‘real world practice’ where clinics and health insurance companies offering packages of IUI treatment during multiple cycles rather than IUI treatment during one cycle only (Dutch Society of Obstetrics and Gynaecology (NVOG), 2011; Dickey et al., 2002; Custers et al., 2008; ESHRE Capri Workshop Group, 2009; Haagen et al., 2010, 2013; Merviel et al., 2010). Our cumulative cost-effectiveness analysis shows that the more cycles patients have, the lower the ICER or costs per additional pregnancy achieved with HMG rather than clomiphene citrate.
The relationship of total progressive motile sperm count with the outcome of IUI? An analysis of 5171 cycles
2022, Gynecological EndocrinologyTechniques used for IUI: Is it time for a change?
2017, Human Reproduction
Esther Haagen is a third-year gynaecologist-in-training at the Department of Obstetrics and Gynaecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. She is currently undertaking a PhD at the Radboud University Nijmegen Medical Centre within a research group interested in clinical practice guidelines, performance indicators and implementation strategies to improve infertility care. Her research is focused on intrauterine insemination care.